Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein
AssigneeGenetics Institute, Inc.
InventorsMeike Lorenz, Ron Kriz, Nadine Weich, Gray D. Shaw
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenetics Institute, Inc.
InventorsMeike Lorenz, Ron Kriz, Nadine Weich, Gray D. Shaw
Estimating the term…
The invention provides isolated nucleic acids molecules, designated SLIC-1 nucleic acid molecules, which encode novel P-selectin glycoprotein ligand (PSGL-1) binding molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SLIC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a SLIC-1 gene has been introduced or disrupted. The invention still further provides isolated SLIC-1 proteins, fusion proteins, antigenic peptides and anti-SLIC-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO:2, wherein the polypeptide binds or interacts with the cytoplasmic domain of a PSGL-1 protein.
An isolated polypeptide comprising a fragment of the amino acid sequence set forth in SEQ ID NO:2, wherein the polypeptide binds or interacts with the cytoplasmic domain of a PSGL-1 protein, and wherein the fragment comprises at least amino acids 1-226 of SEQ ID NO:2.
An isolated polypeptide encoded by a nucleic acid molecule comprising a nucleotide sequence set forth in SEQ ID NQ:1, wherein the polypeptide binds or interacts with the cytoplasmic domain of a PSGL-1 protein.
A polypeptide comprising amino acids 1-226 of SEQ ID NO:2, which is encoded by a nucleic acid molecule comprising a nucleotide sequence which is at least 95% identical to a nucleic acid comprising the nucleotide sequence set forth in SEQ ID NO:1, wherein the polypeptide binds or interacts with the cytoplasmic domain of a PSGL-1 protein.
A polypeptide comprising amino acids 1-226 of SEQ ID NO:2, wherein the polypeptide is at least 95% identical to the amino acid sequence set forth in SEQ ID NO:2, wherein the polypeptide binds or interacts with the cytoplasmic domain of a PSGL-1 protein.
Dependencies are inferred from the claim text.